Safety of eosinophil depletion

David J. Jackson, Ariel Munitz

Source: Eur Respir Monogr 2022; 95: 238-252

Congress or journal article abstractFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
David J. Jackson, Ariel Munitz. Safety of eosinophil depletion. Eur Respir Monogr 2022; 95: 238-252

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Enhancement of eosinophil apoptosis by antihistamines
Source: Eur Respir J 2004; 24: Suppl. 48, 354s
Year: 2004

Safety of sputum induction
Source: Eur Respir J 2002; 20: 9S-18S
Year: 2002

Theophylline drip infusion reduces peripheral blood eosinophil counts and ECP (eosinophil cationic protein) level on acute exacerbation of asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 108s
Year: 2002

LSC Abstract – Changes of peripheral blood eosinophil activity during allergen-induced late-phase airway inflammation in asthma
Source: International Congress 2016 – Clinical characteristics of asthma
Year: 2016

Platelet depletion abolishes neutrophil recruitment in non-allergic murine models of acute inflammation
Source: Eur Respir J 2006; 28: Suppl. 50, 760s
Year: 2006

Eosinophil degranulation status in allergic rhinitis: observations before and during seasonal allergen exposure
Source: Eur Respir J 2004; 24 : 750-757
Year: 2004

Biological monitoring of cellular effects of omalizumab with basophil degranulation test (BAT) in severe asthma
Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E
Year: 2011

Economic burden of severe asthma associated with blood eosinophil elevation before introduction of Monoclonal Antibody Therapy
Source: International Congress 2019 – Asthma and allergies worldwide
Year: 2019

Removal of extracellular ATP improves fMLP-induced neutrophil chemotaxis
Source: International Congress 2016 – Infections, sepsis, and pulmonary embolism
Year: 2016

Neutrophil activation in asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 400s
Year: 2003

Role of sputum eosinophil levels in the assessment of asthma treatment
Source: Eur Respir J 2004; 24: Suppl. 48, 579s
Year: 2004

Simvastatin suppresses the activity of Th2 and Tc2 cells in atopic asthma and in COPD
Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs
Year: 2014

Effect of the combination of doxofylline and montelukast on LPS-induced leukocyte migration to the lung
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014

Effects of N-acetylcysteine and salbutamol on neutrophil migration and release of interleukin-8 and elastase by neutrophils in vitro
Source: Eur Respir J 2004; 24: Suppl. 48, 579s
Year: 2004

Systemic characterization of macrophage phenotypes in allergic airway inflammation
Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation
Year: 2014

Elevated IL-10 level but not cysteinyl leukotrienes (CysLT) release from leukocytes in vitro correlates with good response to treatment with montelukast in asthmatic patients
Source: International Congress 2014 – Asthma and COPD management
Year: 2014

Short term effects of alpha1-antitrypsin substitution therapy on the degranulation of neutrophil granulocytes
Source: Annual Congress 2012 - Update on neutrophil and macrophage function in COPD
Year: 2012

Regulation of eosinophil and neutrophil apoptosis by histone hyperacetylation
Source: Eur Respir J 2003; 22: Suppl. 45, 572s
Year: 2003

Safety of sputum induction in asthmatic children
Source: Eur Respir J 2003; 22: Suppl. 45, 399s
Year: 2003

Histone deacetylation and acetylation status in memory T lymphocytes relates to allergen-induced eosinophil inflammation in lung
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014